This review found no evidence that statins were associated with intracerebral haemorrhage, and if there was a risk, it was small and outweighed by the cardiovascular benefits of treatment. Based on the presented evidence, these conclusions appear to be reliable.
Searching
The authors searched 17 electronic databases, including MEDLINE, The Cochrane Library and ClinicalTrials.gov, from inception to June 2011. Search terms were reported. They searched conference proceedings and the bibliographies of relevant publications, and they contacted experts to identify other studies. The search was not restricted by language or publication status.
Study selection
Studies were eligible for inclusion if they were randomised controlled trials (RCTs) or observational studies that included data on the frequency of intracerebral haemorrhage and statin exposure.
Included studies had a variety of patient populations on statin treatment, including patients with coronary artery disease, type 2 diabetes, hypercholesterolaemia, recent myocardial infarction, hypertension plus other coronary heart disease risk factors, and a history of stroke or transient ischaemic attack.
Two reviewers independently selected studies for inclusion, with disagreements resolved through discussion and consensus.
Assessment of study quality
Methodological quality was assessed using the Jadad criteria for RCTs (up to five points, based on randomisation, concealment of allocation, blinding, and description of withdrawals), and using the Downs and Black checklist for observational studies (up to 32 points based on quality of reporting, internal and external validity, and statistical power).
The authors did not state how many reviewers performed the assessment.
Data extraction
Data were extracted on key study characteristics, with risk ratios and related 95% confidence intervals for dichotomous outcomes. Confidence intervals were converted to standard errors using standard formulae. Double data entry suggests that two reviewers performed the extraction.
Methods of synthesis
Pooled risk ratios and 95% confidence intervals were calculated using the DerSimonian and Laird random-effects model. The degree of statistical inconsistency between pooled studies was assessed using Ι². Pooled risk ratios were calculated separately for RCTs, cohort studies and case-control studies.
Sensitivity analyses were conducted by recalculating the pooled values without one study at a time, by using a fixedeffect model, and by assessing the relationship between outcome and study characteristics, including length of followup, methodological quality, trial dates, disease incidence, statin efficacy, statin type, ethnicity and prevention status, using a random-effects meta-regression.
